Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > BVXV BiondVax制药 > Detailed Quotes

BVXV BiondVax制药

Watchlist
2.650
+0.060+2.32%
Close  02/03 16:00 ET
2.640
-0.010-0.38%
Post Mkt Price 02/03 19:19 ET
High
2.677
Open
2.570
Turnover
230.58K
Low
2.510
Pre Close
2.590
Volume
88.57K
Market Cap
6.06M
P/E(TTM)
Loss
52wk High
22.900
Shares
2.29M
P/E(Static)
Loss
52wk Low
2.370
Float Cap
4.06M
Bid/Ask %
-33.33%
Historical High
619.999
Shs Float
1.53M
Volume Ratio
1.33
Historical Low
2.370
Dividend TTM
--
Div Yield TTM
--
P/B
2.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
5.78%
Amplitude
6.45%
Avg Price
2.603
Lot Size
1
Float Cap
4.06M
Bid/Ask %
-33.33%
Historical High
619.999
Shs Float
1.53M
Volume Ratio
1.33
Historical Low
2.370
Dividend TTM
--
P/B
2.29
Dividend LFY
--
Turnover Ratio
5.78%
Amplitude
6.45%
Avg Price
2.603
Lot Size
1
Price Forecast

News

Comment

Company Overview More
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
CEO: Mr. Amir Reichman
Market: NASDAQ
Listing Date: 05/12/2015
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist